
0.34 Delayed Data As of Mar 23 | ![]() Today’s Change | 0.16 Today|||52-Week Range 3.09 | -61.63% Year-to-Date |
The 2 analysts offering 12-month price forecasts for Sorrento Therapeutics Inc have a median target of 9.00, with a high estimate of 13.00 and a low estimate of 5.00. The median estimate represents a +2,547.06% increase from the last price of 0.34.
The current consensus among 2 polled investment analysts is to Buy stock in Sorrento Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.